Amiodarone Use and All‐Cause Mortality in Patients With a Continuous‐Flow Left Ventricular Assist Device
Rakesh Gopinathannair(Heart Rhythm Society), Dhanunjaya Lakkireddy(Heart Rhythm Society), Luigi Di Biase(Albert Einstein College of Medicine), Mustafa M. Ahmed(McMaster University), Henri Roukoz(University of Minnesota Medical Center), Ashwin Ravichandran(Saint Vincent's Catholic Medical Center), Naga Venkata K. Pothineni(Central Arkansas Veterans Healthcare System), Amin Al‐Ahmad(St David's Medical Center), Andrea Natale(Texas Cardiac Arrhythmia), Jennifer Cowger(Henry Ford Health System), Geetha Bhat(Advocate Christ Medical Center), Mark S. Slaughter(University of Louisville), Adarsh Bhan(Advocate Christ Medical Center), Jaimin R. Trivedi(University of Louisville)
Cited by 15
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876